๐Ÿ›๏ธ Verified NIH Record โ€ข Updated 2026-02-28

Cannabis and Polysubstance Use: Response Inhibition and Stress Exposure (NCT05261321)

๐Ÿ”ต Active, Not Recruiting Phase1 ๐Ÿ’Š Investigational Drug / Biologic Sponsor: University of British Columbia

๐Ÿฉบ Plain-English Summary (8th-Grade Level)

The purpose of this Phase I non-therapeutic trial is to examine the neurological effects of cannabis on stress reactivity and inhibition in healthy cannabis users. We expect differences between high ratio CBD:THC cannabis oil, low ratio CBD:THC cannabis oil, and/or placebo on outcome measures.

Who can join: Review the eligibility criteria below.

Location: B.R.A.I.N. Lab, Institute of Mental Health, Faculty of Medicine, University of British Columbia โ€” Vancouver, British Columbia

Age range: 19 Years to 35 Years

๐Ÿ“‹ "Do I Qualify?" โ€” 1-Minute Self Screener

Instant Checklist

Full eligibility criteria are available on the official NIH protocol. View the criteria โ†—

๐Ÿ“ All Participating Trial Locations (1 Sites)

  • B.R.A.I.N. Lab, Institute of Mental Health, Faculty of Medicine, University of British Columbia โ€” Vancouver, British Columbia

๐Ÿ’ฐ Cost, Insurance & Patient Rights

  • 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
  • Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
  • Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

Explore by condition: All Healthy clinical trials

๐Ÿ’ก How to Participate

  1. Check the checklist above to see if you may qualify.
  2. Review the official NIH record below to find the coordinating site.
  3. Ask about the visit schedule, what is covered at no cost, and any travel support.
  4. Confirm with your own doctor before making a decision.
๐Ÿ›๏ธ View Official NIH Record โ†—